172 related articles for article (PubMed ID: 25368235)
1. Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.
Koido S; Kan S; Yoshida K; Yoshizaki S; Takakura K; Namiki Y; Tsukinaga S; Odahara S; Kajihara M; Okamoto M; Ito M; Yusa S; Gong J; Sugiyama H; Ohkusa T; Homma S; Tajiri H
Anticancer Res; 2014 Nov; 34(11):6353-61. PubMed ID: 25368235
[TBL] [Abstract][Full Text] [Related]
2. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.
Koido S; Homma S; Okamoto M; Takakura K; Mori M; Yoshizaki S; Tsukinaga S; Odahara S; Koyama S; Imazu H; Uchiyama K; Kajihara M; Arakawa H; Misawa T; Toyama Y; Yanagisawa S; Ikegami M; Kan S; Hayashi K; Komita H; Kamata Y; Ito M; Ishidao T; Yusa S; Shimodaira S; Gong J; Sugiyama H; Ohkusa T; Tajiri H
Clin Cancer Res; 2014 Aug; 20(16):4228-39. PubMed ID: 25056373
[TBL] [Abstract][Full Text] [Related]
3. [The case of a patient with peritoneal metastasis from cholangiocarcinoma who responded to adoptive immunotherapy and cetuximab].
Kan N; Yoshikawa K; Matsushita N; Fujii T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1759-61. PubMed ID: 24393913
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
[TBL] [Abstract][Full Text] [Related]
5. Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study.
Marumoto M; Yamasaki T; Marumoto Y; Saeki I; Harima Y; Urata Y; Hidaka I; Ishikawa T; Takami T; Segawa M; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Hepatogastroenterology; 2014; 61(129):162-7. PubMed ID: 24895814
[TBL] [Abstract][Full Text] [Related]
6. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
Ishii M; Itano O; Morinaga J; Shirakawa H; Itano S
PLoS One; 2022; 17(4):e0266707. PubMed ID: 35452492
[TBL] [Abstract][Full Text] [Related]
7. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
8. External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma.
Chen SC; Chen MH; Li CP; Chen MH; Chang PM; Liu CY; Tzeng CH; Liu YM; Yen SH; Chao Y; Huang PI
Hepatogastroenterology; 2015; 62(137):102-7. PubMed ID: 25911877
[TBL] [Abstract][Full Text] [Related]
9. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
Dong Z; Liao B; Shen W; Sui C; Yang J
Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
[TBL] [Abstract][Full Text] [Related]
10. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.
Higuchi R; Yamamoto M; Hatori T; Shimizu K; Imai K; Takasaki K
Surg Today; 2006; 36(6):559-62. PubMed ID: 16715430
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA.
Junking M; Grainok J; Thepmalee C; Wongkham S; Yenchitsomanus PT
Tumour Biol; 2017 Oct; 39(10):1010428317733367. PubMed ID: 29034817
[TBL] [Abstract][Full Text] [Related]
13. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
[TBL] [Abstract][Full Text] [Related]
14. Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.
Marciano R; Servetto A; Bianco C; Bianco R
J Med Case Rep; 2017 Sep; 11(1):273. PubMed ID: 28946921
[TBL] [Abstract][Full Text] [Related]
15. Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.
Ding DY; Gan XJ; Zhang JN; Hou GJ; Tao QF; Sun DP; Li W; Yang Y; Ding WB; Yu J; Liu L; Yang F; Zhou WP; Yuan SX
Br J Cancer; 2023 Mar; 128(5):907-917. PubMed ID: 36526676
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
Kobayashi M; Sakabe T; Abe H; Tanii M; Takahashi H; Chiba A; Yanagida E; Shibamoto Y; Ogasawara M; Tsujitani S; Koido S; Nagai K; Shimodaira S; Okamoto M; Yonemitsu Y; Suzuki N; Nagaya M;
J Gastrointest Surg; 2013 Sep; 17(9):1609-17. PubMed ID: 23877328
[TBL] [Abstract][Full Text] [Related]
17. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.
Gerhardt T; Rings D; Höblinger A; Heller J; Sauerbruch T; Schepke M
Z Gastroenterol; 2010 Jan; 48(1):28-32. PubMed ID: 20072993
[TBL] [Abstract][Full Text] [Related]
18. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
Patkowski W; Stankiewicz R; Grąt M; Krasnodębski M; Kornasiewicz O; Krawczyk M
Transplant Proc; 2014 Oct; 46(8):2774-6. PubMed ID: 25380915
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
Kasai K; Kooka Y; Suzuki Y; Suzuki A; Oikawa T; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Takikawa Y
Ann Surg Oncol; 2014 Oct; 21(11):3638-45. PubMed ID: 24817369
[TBL] [Abstract][Full Text] [Related]
20. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
